Raised $33M across disclosed rounds.[1][2][3][5][11][12]

Series A closed June 2022, led by Coatue.[1][2][3][5][11]

post-money valuation is not publicly disclosed.

Named investors include Lux Capital, General Catalyst, Haystack, Fifty Years, Alec Nielsen, Coatue, Hummingbird Ventures, Caffeinated Capital.[1][3][5][11][12]

Alfredo Andere, Co-Founder and CEO[3][4][5][6][12][15][16][18][39][17][19][20][31]

Kyle Giffin, Co-Founder[3][4][5][6][12][15][16][18][39]

Kenny Workman, Co-Founder and CTO[3][4][5][6][12][15][16][18][39][17][19][20][31]

Hannah Han L., Head of Product[4][15][17][18][19][20][31][39]

Jordan Ramsay, Chief Operating Officer[4][15][17][18][19][20][31][39]

Max Smolin, Technical Lead[4][15][17][18][19][20][31][39]

Platform Capabilities Comparison Overview[4][15][17][18][19][20][31][39]

Seqera · seqera.io · Named by CB Insights as a top Latch Bio competitor; the overlap is the same job to be done, running and orchestrating bioinformatics pipelines in the cloud, which is the workflow-orchestration layer Latch also sells (Nextflow, Snakemake, Python).[32][33]

Manifold · manifold.ai · Named by CB Insights as a top Latch Bio competitor; the overlap is the same buyer and workflow, research teams exploring cohorts and managing bioinformatics data in a shared platform rather than stitching together separate tools.[32]

Pluto Biosciences · plutobio.com · Named by CB Insights as a top Latch Bio competitor; the overlap is the same job to be done, letting life-science teams visualize and analyze complex biological data without building their own computational stack.[32]

The customer proof is company-sourced only. No independent source in this ledger confirms it.[7]

Ask for one referenceable production customer.

Not a recommendation. The first thing this ledger cannot answer.

Filled in the side panel for invited readers. This card carries sourced facts only.